China VenturesChina Ventures 中华创投协会DEAL MARKETPLACE
IPO

11 Nov 2026China VenturesZhitong finance

Xinhehua raises HK$262m in Hong Kong IPO

Sichuan Xinhehua raised HK$262m in a Hong Kong IPO priced at HK$40.2 a share, with its retail tranche 2,191 times covered and the stock up about 71% on debut.

Xinhehua raises HK$262m in Hong Kong IPO
Image: China Ventures

What happened

Sichuan Xinhehua Traditional Chinese Medicine Pieces raised HK$262m in its Hong Kong IPO on 11 November, selling 6.52m H shares at HK$40.2 each. The retail tranche was 2,191 times covered and the stock closed its first day up about 71%. Net proceeds were HK$197m.

The numbers

ItemFigure
Gross proceedsHK$262m
Shares sold6.52m H shares
Offer priceHK$40.2
Retail oversubscription2,191 times
First-day gainAbout 71%
Net proceedsHK$197m

Why it matters

Xinhehua supplies prepared herbal medicines to hospitals and pharmacies. It is a fragmented market where scale and quality certification matter more than brand, and the listing gives the company capital to expand processing capacity and consolidate smaller suppliers.

The counter-argument is that a 71% first-day jump on a 2,191-times retail book is a liquidity event, not a valuation: retail demand can overshoot and reverse. The more durable signal is that Hong Kong will fund consumption-linked healthcare assets with real revenue, which have priced more conservatively than AI or biotech this year.

What to watch

  • Deployment of the HK$197m net proceeds into capacity.
  • Any acquisition of smaller suppliers.
  • Whether the debut gain holds after the retail book clears.

Original source: Zhitong Finance · 11 Nov 2026

All insights ↗